Press release
Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030, predicts Roots Analysis
Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings.
For additional details, please visit
https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
A detailed assessment of the current market landscape of drug developers engaged in the development of psychedelic therapeutics.
Tabulated profiles of prominent psychedelic therapeutics developers. shortlisted on the basis of the number of pipeline products).
Detailed profiles of developers of next generation immune checkpoint modulators (shortlisted on the basis having two or more psychedelics-based therapies in phase II clinical studies and above).
An insightful analysis of clinical trial sites where the studies have been / are being conducted for evaluation of various psychedelic therapeutics.
A list of key opinion leaders (KOLs) within this domain, and detailed 2×2 matrices to assess the relative experience of key individuals who were shortlisted based on their contributions (in terms of involvement in various clinical studies) to this field.
A detailed analysis of nearly 545 grants that have been awarded to research institutes engaged in psychedelic therapeutics projects, in the period between 2015 and 2020 (till May).
An analysis of the partnerships that have been established in the recent past (2017-2020 till May),
A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2017-2020.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Target Disease Indication
Anxiety and Depression
Trauma
Pain Disorder
Sleep related Disorder
Origin of Psychedelic Substance
Natural
Synthetic
Type of Psychedelic Substance
Gamma-hydroxybutyrate
Ketamine
MDMA
Psilocybin
Route of Administration
Oral
Intranasal
Sublingual
Key Geographies
North America
Europe
Asia-Pacific
For additional details, please visit
https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html
Transcripts of interviews held with the following senior level representatives of stakeholder companies
Andrew Chadeayne (Founder & Chief Executive Officer, CaaMTech)
Janakan Krishnarajah (Chief Operating Officer and Chief Medical Officer, iX Biopharma)
Alexander Speiser (Chief Operating Officer, Orthogonal Thinker)
Tracy Cheung, (Chief Communications Officer, COMPASS Pathways)
Key companies covered in the report
Celon Pharma
iX Biopharma
MAPS Public Benefit
MindMed
Janssen Pharmaceuticals
Jazz Pharmaceutical
For additional details, please visit
https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
1. Endocannabinoid System Targeted Therapeutics Market, 2020-2030
2. Depressive Disorders (Major Depression, Bipolar Disorder, Postpartum Depression, Treatment-Resistant Depression and Others): Pipeline Review, Developer Landscape and Competitive Insights, 2019
3. Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights
4. Neoantigen Targeted Therapies Market, 2019-2030
5. Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030, predicts Roots Analysis here
News-ID: 2181787 • Views: …
More Releases from Roots Analysis
Microbial Fermentation CMO Market Set to Triple by 2035, Fueled by Biologics Boo …
The microbial fermentation contract manufacturing organization (CMO) market is on an exciting growth trajectory, projected to soar from USD 3.6 billion in 2024 to over USD 9.1 billion by 2035. This robust expansion, at a compound annual growth rate (CAGR) of 8.7%, reflects the rising demand for biologics and the increasing trend of outsourcing microbial fermentation processes to specialized CMOs, according to a comprehensive new report by Roots Analysis.
Why Microbial…
Peptide Synthesis Market Set to Double by 2035, Driven by Surge in Outsourcing a …
In a world where precision medicine is rapidly reshaping healthcare, the global peptide synthesis market is emerging as a quiet powerhouse. According to a comprehensive new report from Roots Analysis, the sector is poised to leap from a $2.8 billion valuation in 2024 to an impressive $5.1 billion by 2035, growing at a steady 5.5% compound annual growth rate (CAGR). This growth is fueled by a perfect storm of scientific…
Global Needles Market Set to Surpass $14.7 Billion by 2035, Fueled by Chronic Di …
In a world where chronic diseases like diabetes, cancer, and heart conditions are on the rise, the humble needle has become an unsung hero of modern medicine. According to a new report from Roots Analysis, the global needles market is poised for remarkable growth-projected to leap from $8.1 billion in 2025 to over $14.7 billion by 2035, growing at a steady 6.1% annual clip. This surge isn't just about numbers;…
ADC Contract Manufacturing Market Set to Soar, Reaching USD 6.8 Billion by 2035
In the fast-evolving world of biopharmaceuticals, the demand for precision and innovation has never been higher. Nowhere is this more evident than in the rapidly expanding market for Antibody-Drug Conjugate (ADC) contract manufacturing. According to a comprehensive new report from Roots Analysis, the global ADC contract manufacturing market is poised for remarkable growth-projected to surge from USD 1.79 billion in 2024 to over USD 6.8 billion by 2035, at a…
More Releases for Psychedelic
uniMIND Symposium: Exchange on psychedelic research
For the second time, the international academic network uniMIND is organizing a conference focusing on current research around psychedelic topics. The symposium will take place in Maastricht on April 9, 2022. This year's cooperation partner is Maastricht University, one of the most renowned centers of psychedelic research worldwide.
The interest among students in the psychedelic research field continues to grow across disciplines such as psychology, medicine, neuroscience, philosophy, as well as…
Psychedelic Drugs Market: global outlook and overview 2021-2031
Psychedelic Drugs Market: Evolution Contours
Interest in psychedelic medicine has reemerged in psychiatry after a brief period of prohibition of the use of psychedelic substances-from 1950s to the early 1970. Unrefutably, psychedelics or serotonergic hallucinogens show promising potential to treat mood disorders and alcohol dependence. Especially lysergic acid diethylamide (LSD) drug has shown significant safety and tolerability in end-of-life psychological distress.
Read Report Overview: https://www.transparencymarketresearch.com/psychedelic-drugs-market.html
The prohibitive legislatures and discontinuation of research…
Psychedelic Drugs Market 2021: Future Prospects With Covid-19 Impact Analysis 20 …
Psychedelic Drugs report helps clients to be acquainted with new opportunities in the Psychedelic Drugs industry and most important customers for the business growth and increased revenue. This market research report also evaluates the market status, market share, current trends, growth rate, future trends, market drivers, opportunities, challenges, risks, entry barriers, sales channels, and distributors. An expert team of innovative analysts, enthusiastic forecasters, knowledgeable researchers and experienced industry experts take…
Psychedelic Drugs Market 2021: Future Prospects With Covid-19 Impact Analysis 20 …
Global Psychedelic Drugs market research report is formulated with the exact understanding of customer requirements. Market status at the global and regional level about Psychedelic Drugs industry is offered through this report which helps to gain business insights at the extensive marketplace. In the universal Psychedelic Drugs business report, complex market insights are turned into simpler version with the help of proven tools and techniques and then provided to the…
Psychedelic Drugs Market Share, Growth by Business Developments 2021 to 2028
Psychedelic Drugs market report emphasizes key market dynamics of Psychedelic Drugs industry and covers historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. This market analysis report proves to be a precious source of information with which businesses can achieve a telescopic view of the current market trends, consumer’s demands and preferences, market situations, opportunities and market status. To build an…
U.S. Psychedelic Drugs Market Comprehensive Analysis, Growth Forecast from 2021 …
Client’s requirements are understood well by experts leveraging their expertise and strong knowledge base to identify and evaluate competition and chalk out strategic programs with short-term goals and long-term objectives. It is helpful in knowing the general conditions prevailing in the market, the marketing and pricing strategy of competitors. The report ascertains the reputation of the firm and its products. The market report also contains the drivers and restraints for…
